Skip to main content
Top
Published in: AIDS and Behavior 5/2015

01-05-2015 | Original Paper

Male Partner Influence on Women’s HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of “Understanding”

Authors: Elizabeth T. Montgomery, Ariane van der Straten, Jonathan Stadler, Miriam Hartmann, Busisiwe Magazi, Florence Mathebula, Nicole Laborde, Lydia Soto-Torres

Published in: AIDS and Behavior | Issue 5/2015

Login to get access

Abstract

There is widespread evidence that male partners influence women’s ability and willingness to join HIV prevention trials and to use female-controlled prevention strategies such as microbicide gels. VOICE-C was an ancillary study to the Microbicide Trials Network’s VOICE trial at the Johannesburg site that explored social and structural factors influencing women’s use of study tablets and vaginal gel. Qualitative data were analyzed from 102 randomly-selected VOICE participants interviewed through in-depth interviews (IDI, n = 41); ethnographic interviews (n = 21) or focus group discussions (FGD, n = 40) and 22 male partners interviewed in 14 IDI and 2 FGD. Male partners’ “understanding” pervaded as a central explanation for how male partners directly and indirectly influenced their female partners’ trial participation and product use, irrespective of assignment to the gel or tablet study groups. The meaning behind “understanding” in this context was described by both men and women in two important and complementary ways: (1) “comprehension” of the study purpose including biological properties or effects of the products, and (2) “support/agreeability” for female partners being study participants or using products. During analysis a third dimension of “understanding” emerged as men’s acceptance of larger shifts in gender roles and relationship power, and the potential implications of women’s increased access to biomedical knowledge, services and prevention methods. Despite displays of some female agency to negotiate and use HIV prevention methods, male partners still have a critical influence on women’s ability and willingness to do so. Efforts to increase their understanding of research goals, study design and products’ mechanisms of action could ameliorate distrust, empower men to serve as product advocates, adherence buddies, and foster greater adherence support for women in situations where it is needed. Strategies to address gender norms and the broader implications these have for female-initiated HIV prevention should likewise be integrated into future research and program activities.
Literature
1.
go back to reference Montgomery CM, Lees S, Stadler J, et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733–40.CrossRefPubMed Montgomery CM, Lees S, Stadler J, et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733–40.CrossRefPubMed
2.
go back to reference Montgomery E, van der Straten A, Torjesen K. “Male Involvement” in women and children’s HIV prevention: challenges in definition and interpretation. JAIDS—J Acquir Immune Defic Syndr. 2011;57(5):e114.CrossRef Montgomery E, van der Straten A, Torjesen K. “Male Involvement” in women and children’s HIV prevention: challenges in definition and interpretation. JAIDS—J Acquir Immune Defic Syndr. 2011;57(5):e114.CrossRef
3.
go back to reference Montgomery ET, van der Straten A, Chidanyika A, Chipato T, Jaffar S, Padian N. The importance of male partner involvement for women’s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2010;15:959–69. Montgomery ET, van der Straten A, Chidanyika A, Chipato T, Jaffar S, Padian N. The importance of male partner involvement for women’s acceptability and adherence to female-initiated HIV prevention methods in Zimbabwe. AIDS Behav. 2010;15:959–69.
5.
go back to reference Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet. 2004;363(9419):1415–21.CrossRefPubMed Dunkle KL, Jewkes RK, Brown HC, Gray GE, McIntryre JA, Harlow SD. Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet. 2004;363(9419):1415–21.CrossRefPubMed
6.
go back to reference Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? JAIDS J Acquir Immune Defic Syndr. 2013;63:S122–9.CrossRef Baeten JM, Haberer JE, Liu AY, Sista N. Preexposure prophylaxis for HIV prevention: where have we been and where are we going? JAIDS J Acquir Immune Defic Syndr. 2013;63:S122–9.CrossRef
8.
go back to reference Ware NC, Wyatt MA, Haberer JE, et al. What’s Love Got to Do With It? Explaining Adherence to Oral Antiretroviral Pre-Exposure Prophylaxis for HIV-Serodiscordant Couples. JAIDS J Acquir Immune Defic Syndr. 2012;59(5):463–8. doi:10.1097/QAI.0b013e31824a060b.CrossRef Ware NC, Wyatt MA, Haberer JE, et al. What’s Love Got to Do With It? Explaining Adherence to Oral Antiretroviral Pre-Exposure Prophylaxis for HIV-Serodiscordant Couples. JAIDS J Acquir Immune Defic Syndr. 2012;59(5):463–8. doi:10.​1097/​QAI.​0b013e31824a060b​.CrossRef
9.
go back to reference Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefPubMedCentralPubMed Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefPubMedCentralPubMed
10.
go back to reference Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. New Engl J Med. 2012;367(5):423–34. doi:10.1056/NEJMoa1110711. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana. New Engl J Med. 2012;367(5):423–34. doi:10.​1056/​NEJMoa1110711.
11.
go back to reference Marrazzo J, Ramjee G, Nair G, et al. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofoviremtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003). CROI. Atlanta GA2013. Marrazzo J, Ramjee G, Nair G, et al. Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofoviremtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003). CROI. Atlanta GA2013.
12.
go back to reference van der Straten A, Stadler J, Montgomery E, et al. Women’s experiences with oral and vaginal pre-exposure prophylaxis: The VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.CrossRefPubMedCentralPubMed van der Straten A, Stadler J, Montgomery E, et al. Women’s experiences with oral and vaginal pre-exposure prophylaxis: The VOICE-C qualitative study in Johannesburg, South Africa. PLoS ONE. 2014;9(2):e89118.CrossRefPubMedCentralPubMed
13.
go back to reference Latkin C, Forman V, Knowlton A, Norms SS. Social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56(3):465–76.CrossRefPubMed Latkin C, Forman V, Knowlton A, Norms SS. Social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56(3):465–76.CrossRefPubMed
14.
go back to reference Bronfenbrenner U. Toward an experimental ecology of human development. Am Psychol. 1977;32(7):513–31.CrossRef Bronfenbrenner U. Toward an experimental ecology of human development. Am Psychol. 1977;32(7):513–31.CrossRef
15.
go back to reference Mooney A, Sarangi S. An ecological framing of HIV preventive intervention: a case study of non-government organizational work in the developing world. Health. 2005;9(3):275–96.PubMed Mooney A, Sarangi S. An ecological framing of HIV preventive intervention: a case study of non-government organizational work in the developing world. Health. 2005;9(3):275–96.PubMed
16.
go back to reference Latkin CA, Forman V, Knowlton A, Norms SS. Social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56(3):465–76.CrossRefPubMed Latkin CA, Forman V, Knowlton A, Norms SS. Social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc Sci Med. 2003;56(3):465–76.CrossRefPubMed
17.
go back to reference Montgomery C, Lees S, Stadler J, et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733–40.CrossRefPubMed Montgomery C, Lees S, Stadler J, et al. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733–40.CrossRefPubMed
18.
go back to reference Venables E, Stadler J. ‘The study has taught me to be supportive of her’: empowering women and involving men in microbicide research. Culture, Health and Sex. 2012;14(2):181–94.CrossRef Venables E, Stadler J. ‘The study has taught me to be supportive of her’: empowering women and involving men in microbicide research. Culture, Health and Sex. 2012;14(2):181–94.CrossRef
19.
go back to reference Sahin-Hodoglugil NN, van der Straten A, Cheng H, et al. Degrees of disclosure: a study of women’s covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. Soc Sci Med. 2009;69(10):1547–55.CrossRefPubMed Sahin-Hodoglugil NN, van der Straten A, Cheng H, et al. Degrees of disclosure: a study of women’s covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa. Soc Sci Med. 2009;69(10):1547–55.CrossRefPubMed
20.
go back to reference Montgomery E, Upkong M, White R, van der Straten A. Involving male partners in trials of female-initiated HIV prevention methods in Africa: a review of strategies and evidence. 5th IAS conference on HIV pathogenesis, treatment and prevention, Cape Town, South Africa (poster presentation). 2009. Montgomery E, Upkong M, White R, van der Straten A. Involving male partners in trials of female-initiated HIV prevention methods in Africa: a review of strategies and evidence. 5th IAS conference on HIV pathogenesis, treatment and prevention, Cape Town, South Africa (poster presentation). 2009.
21.
go back to reference Remien R, Stirratt M, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807–14.CrossRefPubMed Remien R, Stirratt M, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807–14.CrossRefPubMed
22.
go back to reference Hunter M. Cultural politics and masculinities: multiple-partners in historical perspective in Kwa-Zulu Natal. Culture Health and Sex. 2005;7(4):389–403.CrossRef Hunter M. Cultural politics and masculinities: multiple-partners in historical perspective in Kwa-Zulu Natal. Culture Health and Sex. 2005;7(4):389–403.CrossRef
Metadata
Title
Male Partner Influence on Women’s HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of “Understanding”
Authors
Elizabeth T. Montgomery
Ariane van der Straten
Jonathan Stadler
Miriam Hartmann
Busisiwe Magazi
Florence Mathebula
Nicole Laborde
Lydia Soto-Torres
Publication date
01-05-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 5/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0950-5

Other articles of this Issue 5/2015

AIDS and Behavior 5/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.